Allkem General Discussion, page-590

The company is being judged on the price it is getting for its product.

Last quarter PLS outperformed on pricing for Spod received. By around 10% (BMX impact etc).

Carb price received was dire here really considering we are in a boom market and $20k T this quarter guidance is better but ain’t setting the house on fire either.

It’s clear ORE could not negotiate contracts. Thank god SH stuck to spot pricing even if it hurt for a while.

From an MC perspective AKE compared to PLS is sitting around the right proportion based on revenue generation.

I don’t necessarily agree with that, as the market should be far more forward looking (resources, downstream etc etc) but it is not currently IMO.

Markets are not always rational and this I think is providing a good opportunity here.

GLTAH